• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中枢大麻素(CB1)受体在大鼠位置条件反射建立中的作用。

Involvement of central cannabinoid (CB1) receptors in the establishment of place conditioning in rats.

作者信息

Chaperon F, Soubrié P, Puech A J, Thiébot M H

机构信息

INSERM U.288, Faculty of Medicine Pitié-Salpêtrière, Paris, France.

出版信息

Psychopharmacology (Berl). 1998 Feb;135(4):324-32. doi: 10.1007/s002130050518.

DOI:10.1007/s002130050518
PMID:9539255
Abstract

The involvement of cannabinoid processes in positive reinforcement was studied using an unbiased, one-compartment, conditioned place preference (CPP) procedure in rats. This was achieved by examining the ability of the selective antagonist of the CB1 cannabinoid receptor subtype, SR 141716, to counteract the CPP supported by classical reinforcers. The acquisition of CPP induced by cocaine (2 mg/kg), morphine (4 mg/kg) and food (standard chow and sucrose pellets) was dose-dependently blocked by pre-pairing administration of SR 141716 (0.03-3 mg/kg). However, SR 141716 (up to 10 mg/kg) did not significantly counteract the expression of cocaine-induced CPP. On the other hand, the synthetic CB receptor agonist, WIN 55212-2 (0.3-1 mg/kg), established a robust place aversion (CPA), as already described with other agonists, and CPP was never observed, even at 100-fold lower doses. The aversive effect of WIN 55212-2 was reversed by SR 141716 (0.3-1 mg/kg), suggesting that it was accounted for by the stimulation of CB1 receptors. These findings indicate that, on their own, CB receptor agonists are unable to generate the processes necessary to induce a pleasurable state in animals, as assessed in place conditioning procedures. Nevertheless, a cannabinoid link may be involved in the neurobiological events, allowing the perception of the rewarding value of various kinds of reinforcers. However, a permanent endogenous cannabinoid tone seems unlikely to be necessary to ensure the organism a basal hedonic level since, given alone, SR 141716 supported neither CPP nor CPA.

摘要

采用无偏倚的单室条件性位置偏爱(CPP)程序,在大鼠中研究大麻素过程在阳性强化中的作用。这是通过检测CB1大麻素受体亚型的选择性拮抗剂SR 141716抵消经典强化物支持的CPP的能力来实现的。可卡因(2mg/kg)、吗啡(4mg/kg)和食物(标准饲料和蔗糖颗粒)诱导的CPP的获得,在与SR 141716(0.03 - 3mg/kg)预配对给药时呈剂量依赖性阻断。然而,SR 141716(高达10mg/kg)并未显著抵消可卡因诱导的CPP的表达。另一方面,合成的CB受体激动剂WIN 55212 - 2(0.3 - 1mg/kg)产生了强烈的位置厌恶(CPA),正如其他激动剂所描述的那样,即使在低100倍的剂量下也未观察到CPP。SR 141716(0.3 - 1mg/kg)逆转了WIN 55212 - 2的厌恶作用,表明这是由CB1受体的刺激引起的。这些发现表明,就其本身而言,CB受体激动剂无法产生在位置条件化程序中评估的诱导动物愉悦状态所需的过程。然而,大麻素联系可能参与神经生物学事件,从而使动物能够感知各种强化物的奖赏价值。然而,永久性的内源性大麻素张力似乎不太可能是确保机体基本享乐水平所必需的,因为单独给予SR 141716既不支持CPP也不支持CPA。

相似文献

1
Involvement of central cannabinoid (CB1) receptors in the establishment of place conditioning in rats.中枢大麻素(CB1)受体在大鼠位置条件反射建立中的作用。
Psychopharmacology (Berl). 1998 Feb;135(4):324-32. doi: 10.1007/s002130050518.
2
WIN 55,212-2 decreases the reinforcing actions of cocaine through CB1 cannabinoid receptor stimulation.WIN 55,212-2 通过刺激 CB1 大麻素受体降低可卡因的强化作用。
Behav Brain Res. 2003 May 15;141(2):215-22. doi: 10.1016/s0166-4328(02)00370-4.
3
Cannabinoid CB1 receptors of the dorsal hippocampus are important for induction of conditioned place preference (CPP) but do not change morphine CPP.背侧海马体的大麻素CB1受体对条件性位置偏爱(CPP)的诱导很重要,但不会改变吗啡诱导的CPP。
Brain Res. 2007 Aug 13;1163:130-7. doi: 10.1016/j.brainres.2007.06.015. Epub 2007 Jun 16.
4
Basolateral amygdala CB1 cannabinoid receptors mediate nicotine-induced place preference.基底外侧杏仁核CB1大麻素受体介导尼古丁诱导的位置偏爱。
Prog Neuropsychopharmacol Biol Psychiatry. 2014 Jun 3;51:65-71. doi: 10.1016/j.pnpbp.2014.01.010. Epub 2014 Jan 24.
5
Functional interaction between morphine and central amygdala cannabinoid CB1 receptors in the acquisition and expression of conditioned place preference.吗啡和中杏仁核大麻素 CB1 受体在条件性位置偏爱获得和表达中的功能相互作用。
Behav Brain Res. 2011 Jun 20;220(1):1-8. doi: 10.1016/j.bbr.2011.01.023. Epub 2011 Jan 22.
6
Intravenous self-administration of the cannabinoid CB1 receptor agonist WIN 55,212-2 in rats.大鼠体内大麻素CB1受体激动剂WIN 55,212-2的静脉自我给药
Psychopharmacology (Berl). 2001 Aug;156(4):410-6. doi: 10.1007/s002130100734.
7
Role of intra-accumbal cannabinoid CB1 receptors in the potentiation, acquisition and expression of morphine-induced conditioned place preference.伏隔核内大麻素 CB1 受体在增强、获得和表达吗啡诱导的条件性位置偏爱中的作用。
Behav Brain Res. 2013 Jun 15;247:125-31. doi: 10.1016/j.bbr.2013.03.022. Epub 2013 Mar 21.
8
Involvement of CB1 receptors in the ventral tegmental area in the potentiation of morphine rewarding properties in acquisition but not expression in the conditioned place preference model.在条件性位置偏爱模型中,腹侧被盖区中的 CB1 受体参与增强吗啡奖赏属性的获得,但不参与表达。
Behav Brain Res. 2013 Jun 15;247:259-67. doi: 10.1016/j.bbr.2013.03.015. Epub 2013 Mar 16.
9
Effect of the CB1 cannabinoid agonist WIN 55212-2 on the acquisition and reinstatement of MDMA-induced conditioned place preference in mice.大麻素 CB1 受体激动剂 WIN 55212-2 对 MDMA 诱导的小鼠条件性位置偏爱获得和复吸的影响。
Behav Brain Funct. 2010 Mar 22;6:19. doi: 10.1186/1744-9081-6-19.
10
A cannabinoid receptor antagonist attenuates conditioned place preference but not behavioural sensitization to morphine.一种大麻素受体拮抗剂可减弱条件性位置偏爱,但不会减弱对吗啡的行为敏化。
Brain Res. 2004 Nov 12;1026(2):244-53. doi: 10.1016/j.brainres.2004.08.027.

引用本文的文献

1
The Use of Cannabidiol in Treating Psychiatric Disorders: A Systematic Review.大麻二酚在治疗精神疾病中的应用:一项系统综述。
Psychiatry Clin Psychopharmacol. 2021 Jun 1;31(2):226-232. doi: 10.5152/pcp.2021.21743. eCollection 2021 Jun.
2
Δ-tetrahydrocannabinol discrimination: Effects of route of administration in mice.Δ-四氢大麻酚辨别:给药途径对小鼠的影响。
Drug Alcohol Depend Rep. 2023 Nov 10;9:100205. doi: 10.1016/j.dadr.2023.100205. eCollection 2023 Dec.
3
Δ-Tetrahydrocannabinol Effects on Respiration and Heart Rate Across Route of Administration in Female and Male Mice.
Δ-四氢大麻酚对女性和男性小鼠给药途径的呼吸和心率的影响。
Cardiovasc Toxicol. 2023 Dec;23(11-12):349-363. doi: 10.1007/s12012-023-09810-9. Epub 2023 Sep 20.
4
Daily Δ-Tetrahydrocannabinol and Withdrawal Increase Dopamine D-D Receptor Heteromer to Mediate Anhedonia- and Anxiogenic-like Behavior Through a Dynorphin and Kappa Opioid Receptor Mechanism.每日服用Δ-四氢大麻酚及戒断会增加多巴胺D-D受体异聚体,通过强啡肽和κ阿片受体机制介导快感缺失和焦虑样行为。
Biol Psychiatry Glob Open Sci. 2022 Jul 30;3(3):550-566. doi: 10.1016/j.bpsgos.2022.07.003. eCollection 2023 Jul.
5
Context-dependent effects of the CB1 receptor antagonist rimonabant on morphine-induced behavioral sensitization in female mice.CB1受体拮抗剂利莫那班对雌性小鼠吗啡诱导的行为敏化的情境依赖性影响。
Front Pharmacol. 2023 Feb 6;14:1100527. doi: 10.3389/fphar.2023.1100527. eCollection 2023.
6
Neutral CB1 Receptor Antagonists as Pharmacotherapies for Substance Use Disorders: Rationale, Evidence, and Challenge.中性 CB1 受体拮抗剂作为物质使用障碍的药物治疗:原理、证据和挑战。
Cells. 2022 Oct 17;11(20):3262. doi: 10.3390/cells11203262.
7
Negative allosteric modulation of CB cannabinoid receptor signaling suppresses opioid-mediated reward.负变构调节大麻素 CB 受体信号抑制阿片介导的奖赏。
Pharmacol Res. 2022 Nov;185:106474. doi: 10.1016/j.phrs.2022.106474. Epub 2022 Sep 28.
8
Therapeutic potential of PIMSR, a novel CB1 receptor neutral antagonist, for cocaine use disorder: evidence from preclinical research.PIMSR 作为一种新型的 CB1 受体中性拮抗剂,在可卡因使用障碍治疗中的潜力:来自临床前研究的证据。
Transl Psychiatry. 2022 Jul 18;12(1):286. doi: 10.1038/s41398-022-02059-w.
9
Obesity as a Condition Determined by Food Addiction: Should Brain Endocannabinoid System Alterations Be the Cause and Its Modulation the Solution?肥胖作为一种由食物成瘾决定的状况:大脑内源性大麻素系统的改变应是其成因且对该系统的调节应是解决之道吗?
Pharmaceuticals (Basel). 2021 Sep 29;14(10):1002. doi: 10.3390/ph14101002.
10
The Effects of Repeated Morphine Treatment on the Endogenous Cannabinoid System in the Ventral Tegmental Area.重复给予吗啡对腹侧被盖区内源性大麻素系统的影响。
Front Pharmacol. 2021 Apr 16;12:632757. doi: 10.3389/fphar.2021.632757. eCollection 2021.